The immune system in atherosclerosis

[1]  G. Hansson,et al.  Immunotherapy With Tolerogenic Apolipoprotein B-100–Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice , 2011, Circulation.

[2]  K. Moore,et al.  Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. , 2010, Cell metabolism.

[3]  E. Podrez,et al.  Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands , 2010, Nature.

[4]  P. Tipping,et al.  Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis , 2010, The Journal of Immunology.

[5]  C. Uyttenhove,et al.  B cell depletion reduces the development of atherosclerosis in mice , 2010, The Journal of experimental medicine.

[6]  C. Glass,et al.  ATVB in Focus Nuclear Receptors in Metabolism and Cardiovascular Disease , 2010 .

[7]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[8]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[9]  P. Kovanen,et al.  Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation , 2010, PloS one.

[10]  M. Björkholm,et al.  Tackling Two Diseases with HDL , 2010, Science.

[11]  A. Tall,et al.  ABCA1 and ABCG1 Protect Against Oxidative Stress–Induced Macrophage Apoptosis During Efferocytosis , 2010, Circulation research.

[12]  E. Puré,et al.  Targeted Deletions of Cyclooxygenase-2 and Atherogenesis in Mice , 2010, Circulation.

[13]  G. Paulsson-Berne,et al.  Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis , 2010, The Journal of experimental medicine.

[14]  C. Glass,et al.  Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells , 2010, Nature Reviews Immunology.

[15]  R. Klingenberg,et al.  Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[16]  D. Lloyd‐Jones,et al.  Risk Prediction in Cardiovascular Medicine Cardiovascular Risk Prediction Basic Concepts, Current Status, and Future Directions , 2010 .

[17]  K. Ley,et al.  Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice , 2010, Circulation.

[18]  G. Hansson,et al.  Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice. , 2010, Atherosclerosis.

[19]  P. Teeling,et al.  Differential expression of interleukin‐17 family cytokines in intact and complicated human atherosclerotic plaques , 2010, The Journal of pathology.

[20]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[21]  B. Dahlöf,et al.  Cardiovascular disease risk factors: epidemiology and risk assessment. , 2010, The American journal of cardiology.

[22]  G. Hansson,et al.  Innate immune signals in atherosclerosis. , 2010, Clinical immunology.

[23]  John Andersson,et al.  Adaptive immunity and atherosclerosis. , 2010, Clinical immunology.

[24]  C. Weyand,et al.  Dendritic cells in atherosclerotic disease. , 2010, Clinical immunology.

[25]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[26]  D. Böckler,et al.  Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice1 , 2009, The Journal of Immunology.

[27]  NaotoSasaki,et al.  Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice , 2009 .

[28]  K. Hirata,et al.  Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice , 2009, Circulation.

[29]  L. Joosten,et al.  Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. , 2009, Biochemical and biophysical research communications.

[30]  L. Jacobsson,et al.  No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. , 2009, Arthritis and rheumatism.

[31]  C. Uyttenhove,et al.  Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis , 2009, The Journal of experimental medicine.

[32]  M. Tsan,et al.  Heat shock proteins and immune system , 2009, Journal of leukocyte biology.

[33]  D. Steinberg.  The LDL modification hypothesis of atherogenesis: an update Published, JLR Papers in Press, November 15, 2009. , 2009, Journal of Lipid Research.

[34]  S. Gordon,et al.  The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges Work in the authors' laboratories is funded by the British Heart Foundation. Published, JLR Papers in Press, December 11, 2008. , 2009, Journal of Lipid Research.

[35]  J. Pober,et al.  Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells , 2009, Circulation.

[36]  G. Getz,et al.  Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE−/− mice , 2009, The Journal of experimental medicine.

[37]  A. Silman,et al.  European biologicals registers: methodology, selected results and perspectives , 2008, Annals of the rheumatic diseases.

[38]  Christian Weber,et al.  Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series Editor : Christian Weber Chemokines in Atherosclerosis An Update , 2008 .

[39]  S. Gabriel,et al.  Cardiovascular morbidity and mortality in rheumatoid arthritis. , 2008, The American journal of medicine.

[40]  A. Hamsten,et al.  High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. , 2008, European heart journal.

[41]  Lieping Chen,et al.  CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice , 2008, Circulation.

[42]  A. Tall,et al.  Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins , 2008, Journal of internal medicine.

[43]  Ashley M. Miller,et al.  IL-33 reduces the development of atherosclerosis , 2008, The Journal of experimental medicine.

[44]  A. Daugherty,et al.  Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice. , 2007, The American journal of pathology.

[45]  M. Fishbein,et al.  Role of the JAK/STAT Pathway in the Regulation of Interleukin-8 Transcription by Oxidized Phospholipids in Vitro and in Atherosclerosis in Vivo* , 2007, Journal of Biological Chemistry.

[46]  J. Borén,et al.  Ira Tabas , Kevin Jon Williams and Jan Borén and Therapeutic Implications Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis : Update , 2007 .

[47]  A. Sharpe,et al.  Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. , 2007, The Journal of clinical investigation.

[48]  Ralf Morgenstern,et al.  Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target , 2007, Pharmacological Reviews.

[49]  A. Silman,et al.  Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register , 2007, Arthritis and rheumatism.

[50]  P. Teeling,et al.  Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions , 2007, PloS one.

[51]  S. Kaveri,et al.  Phosphorylcholine-targeting immunization reduces atherosclerosis. , 2007, Journal of the American College of Cardiology.

[52]  P. Kovanen.  Mast cells: multipotent local effector cells in atherothrombosis , 2007, Immunological reviews.

[53]  G. Berglund,et al.  Association Between IgM Against an Aldehyde-Modified Peptide in Apolipoprotein B-100 and Progression of Carotid Disease , 2007, Stroke.

[54]  G. Keren,et al.  Role of Naturally Occurring CD4+CD25+ Regulatory T Cells in Experimental Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[55]  E. Brilakis,et al.  Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events Published, JLR Papers in Press, November 8, 2006. , 2007, Journal of Lipid Research.

[56]  E. Chaikof,et al.  Pathogen-Sensing Plasmacytoid Dendritic Cells Stimulate Cytotoxic T-Cell Function in the Atherosclerotic Plaque Through Interferon-&agr; , 2006, Circulation.

[57]  D. Isenberg,et al.  Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus1 , 2006, The Journal of Immunology.

[58]  Aiqing He,et al.  The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[59]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[60]  K. Mandal,et al.  Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[61]  Anders Gabrielsen,et al.  Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[63]  G. Hansson,et al.  Adoptive Transfer of CD4+ T Cells Reactive to Modified Low-Density Lipoprotein Aggravates Atherosclerosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[64]  R. Flavell,et al.  Natural regulatory T cells control the development of atherosclerosis in mice , 2006, Nature Medicine.

[65]  G. Hansson,et al.  Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[66]  P. Tobias,et al.  Modulation of atherosclerosis in mice by Toll-like receptor 2. , 2005, The Journal of clinical investigation.

[67]  J. Renauld,et al.  Blockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis , 2005, Circulation.

[68]  Jesse D. Roberts,et al.  Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell Recruitment , 2005, Circulation.

[69]  I. Vliegen,et al.  Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. , 2005, Atherosclerosis.

[70]  Jan Hillert,et al.  MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction , 2005, Nature Genetics.

[71]  Per Eriksson,et al.  Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility , 2005, Nature Genetics.

[72]  L. Glimcher,et al.  T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[73]  P. Shah,et al.  Immunomodulation of atherosclerosis: implications for vaccine development. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[74]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[75]  F. Mach,et al.  Differential Expression Patterns of Proinflammatory and Antiinflammatory Mediators During Atherogenesis in Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[76]  Jan Nilsson,et al.  Recombinant Human Antibodies Against Aldehyde-Modified Apolipoprotein B-100 Peptide Sequences Inhibit Atherosclerosis , 2004, Circulation.

[77]  D. Broide,et al.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. , 2004, The Journal of clinical investigation.

[78]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. Hamsten,et al.  Statins in rheumatoid arthritis—two birds with one stone? , 2004, The Lancet.

[80]  R. Schwinger,et al.  TNF and congestive heart failure: therapeutic possibilities , 2004, Expert opinion on therapeutic targets.

[81]  A. Lusis,et al.  Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004, The New England journal of medicine.

[82]  Qingbo Xu,et al.  Autoimmune and inflammatory mechanisms in atherosclerosis. , 2004, Annual review of immunology.

[83]  K. Moore,et al.  Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways , 2004, Nature Medicine.

[84]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[85]  P. Tipping,et al.  The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. , 2003, The American journal of pathology.

[86]  S. Akira,et al.  Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. , 2003, Cardiovascular research.

[87]  J. Witztum,et al.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL , 2003, Nature Medicine.

[88]  G. Berglund,et al.  Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[89]  M. Seishima,et al.  Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[90]  A. Hamsten,et al.  Autoantibodies against modified low-density lipoproteins in coronary artery disease. , 2003, Atherosclerosis.

[91]  C. Come,et al.  Influence of Interferon-&ggr; on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient Mouse , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[92]  T. Cohnert,et al.  Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[93]  J. Witztum,et al.  Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells* , 2003, The Journal of Biological Chemistry.

[94]  S. Youssef,et al.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease , 2002, Nature.

[95]  M. Linton,et al.  B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[96]  Jacob George,et al.  Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. , 2002, Journal of the American College of Cardiology.

[97]  P. Libby,et al.  Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient Mice , 2002, Circulation.

[98]  A. Lusis,et al.  Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.

[99]  J. Borén,et al.  Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.

[100]  A. Daugherty,et al.  IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[101]  G. Hansson,et al.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. , 2002, The Journal of clinical investigation.

[102]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[103]  A. Daugherty,et al.  Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor−/− Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[104]  A. Daugherty,et al.  Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E−/− Mice Through Release of Interferon-&ggr; , 2002, Circulation research.

[105]  M. Lindholm,et al.  Inflammation and cholesterol , 2002 .

[106]  Bernd R Binder,et al.  Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT. , 2002, Blood.

[107]  J. Bluestone,et al.  Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[108]  M. Newell,et al.  T Helper—Cell Phenotype Regulates Atherosclerosis in Mice Under Conditions of Mild Hypercholesterolemia , 2001, Circulation.

[109]  Xinghua Zhou,et al.  Transfer of CD4+ T Cells Aggravates Atherosclerosis in Immunodeficient Apolipoprotein E Knockout Mice , 2000, Circulation.

[110]  A. Daugherty,et al.  Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice , 2000 .

[111]  M. Kurrer,et al.  Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[112]  R. Frye,et al.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.

[113]  J. Farmer.  Pleiotropic effects of statins , 2000, Current atherosclerosis reports.

[114]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[115]  L. Rauova,et al.  Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. , 2000, Journal of autoimmunity.

[116]  G. Hansson,et al.  Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[117]  U. Andersson,et al.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.

[118]  Tzong-Shyuan Lee,et al.  The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[119]  T. Kodama,et al.  The macrophage scavenger receptor type A directs modified proteins to antigen presentation , 1999, European journal of immunology.

[120]  J M Samet,et al.  Epidemiology and risk assessment. , 1998, American journal of epidemiology.

[121]  O. Wiklund,et al.  Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[122]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[123]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[124]  A. Tall,et al.  IFN- g Potentiates Atherosclerosis in ApoE Knock-out Mice , 1997 .

[125]  P. Shah,et al.  Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[126]  Michael Ginsberg,et al.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[127]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[128]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.